We applaud Oldenburg and colleagues for the successful implementation of a community-based intervention to curtail cardiovascular disease (CVD) (1). The authors promote the increased use of aspirin for primary prevention (the aim of which is to reduce the risk for a first heart attack or stroke) among people who meet the criteria established by the 2009 US Preventive Services Task Force. Howeve...

OBJECTIVE To determine whether regular aspirin use (> or =75 mg/day) is independently associated with cardiovascular disease (CVD) and all-cause mortality in community-based patients with type 2 diabetes and no history of CVD. RESEARCH DESIGN AND METHODS Of the type 2 diabetic patients recruited to the longitudinal observational Fremantle Diabetes Study, 651 (50.3%) with no prior CVD history ...

BACKGROUND The net benefit of aspirin in prevention of CVD and nonvascular events remains unclear. Our objective was to assess the impact (and safety) of aspirin on vascular and nonvascular outcomes in primary prevention. DATA SOURCES MEDLINE, Cochrane Library of Clinical Trials (up to June 2011) and unpublished trial data from investigators. STUDY SELECTION Nine randomized placebo-controll...

OBJECTIVE To quantify absolute cardiovascular disease (CVD) risk and treatment in Australian adults. DESIGN, PARTICIPANTS Cross-sectional representative study of 9564 people aged 18 years or more who had participated in the 2011-12 Australian National Health Measures Survey (response rate for those aged 45-74 years: 46.5%). MAIN OUTCOME MEASURES Prior CVD was ascertained and 5-year absolute...

background: evidence shows that in iran alcohol abuse rate may be of concern, especially among the youth. the mental and social health and addiction department of the ministry of health and medical education has designed a plan to prevent, treat, and rehabilitate the patients abusing alcohol in a time period of 2011‑2015. methods: in a 6‑month period, three guiding committees of experts in the ...

INTRODUCTION The EURIKA study was designed to describe the control of cardiovascular disease (CVD) risk factors in a real-world primary prevention setting in Europe, to estimate residual CVD risk, and to assess physicians' attitudes to and perceptions of risk factor management. The present manuscript reports the EURIKA results from Greece. METHODS EURIKA was a multinational, cross-sectional s...

Cardiovascular disease (CVD) was the leading cause of death globally in 2005, responsible for 17.5 million deaths, more than 80% of which occurred in low- and middle-income countries (LMIC). In these regions, CVD occurs at a much younger age than in high-income countries, thereby contributing disproportionately to lost potential years of healthy life as well as lost economic productivity. Many ...

As the leading cause of death in the Western world, cardiovascular disease (CVD) constitutes an enormous public health problem.1 The last 4 decades have been characterized chiefly by the postponement of CVD events and CVD related deaths until older age. Thus, the burden of CVD is increasing in parallel with the increase in life expectancy.2 Within this context, identifying persons with CVD, mea...

Our aim was to assess the efficacy of dietary supplements in the primary prevention of cause-specific death, cardiovascular disease (CVD), and cancer by using meta-analytical approaches. Electronic and hand searches were performed until August 2016. Inclusion criteria were as follows: 1) minimum intervention period of 12 mo; 2) primary prevention trials; 3) mean age ≥18 y; 4) interventions incl...

BACKGROUND Primary care plays a key role in the prevention and management of cardiovascular disease (CVD). We examined primary care practice adherence to recommended care guidelines associated with the prevention and management of CVD for high risk patients. METHODS We conducted a secondary analysis of cross-sectional baseline data collected from 84 primary care practices participating in a l...